Alpha 2.0
Login Register
» Authors » Jens Heider

Jens Heider

Explore the profile of Jens Heider including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 47
Followers 0
Related Specialties
Psychology
Psychiatry
Pharmacology
Top 10 Co-Authors
Annette Schroder
Winfried Rief
Maria Kleinstauber
Michael Witthoft
Tina In-Albon
Rudolf Stark
Katharina Senger
Julia A Glombiewski
Wolfgang Lutz
Julian A Rubel
Published In
Psychother Res
Psychother Psychosom Med Psychol
J Clin Psychol
Psychosom Med
Psychol Med
Affiliations
Soon will be listed here.
Recent Articles
1.
How do young-old and old-old adults benefit from cognitive-behavioral therapy compared to working-age adults? A large multicenter naturalistic study
Wrede N, Hillebrand M, Risch A, Alpers G, Bartholdy S, Brakemeier E, et al.
J Affect Disord . 2025 Jan; 375:456-464. PMID: 39889933
Background: Although meta-analyses suggest comparable efficacy of cognitive-behavioral therapy (CBT) in older adults compared to working-age adults, little is known about its effectiveness in naturalistic settings across different age groups....
2.
Love yourself as a therapist, doubt yourself as an institution? Therapist and institution effects on outcome, treatment length, and dropout
Deisenhofer A, Hehlmann M, Rubel J, Lutz W, Schwartz B, Brascher A, et al.
Psychother Res . 2024 Jun; :1-14. PMID: 38831579
Objective: Research suggests that some therapists achieve better outcomes than others. However, an overlooked area of study is how institution differences impact patient outcomes independent of therapist variance. This study...
3.
Leveraging Single-Case Experimental Designs to Promote Personalized Psychological Treatment: Step-by-Step Implementation Protocol with Stakeholder Involvement of an Outpatient Clinic for Personalized Psychotherapy
Scholten S, Schemer L, Herzog P, Haas J, Heider J, Winter D, et al.
Adm Policy Ment Health . 2024 Mar; 51(5):702-724. PMID: 38467950
Our objective is to implement a single-case experimental design (SCED) infrastructure in combination with experience-sampling methods (ESM) into the standard diagnostic procedure of a German outpatient research and training clinic....
4.
Same same, but different: effects of likelihood framing on concerns about a medical disease in patients with somatoform disorders, major depression, and healthy people
Kube T, Riecke J, Heider J, Glombiewski J, Rief W, Barsky A
Psychol Med . 2023 Jun; 53(16):7729-7734. PMID: 37309182
Background: Research has shown that patients with somatoform disorders (SFD) have difficulty using medical reassurance (i.e. normal results from diagnostic testing) to revise concerns about being seriously ill. In this...
5.
How the integration of normal medical test results can be improved in patients with somatoform disorders-An experimental study
Kube T, Riecke J, Heider J, Ballou S, Glombiewski J, Rief W, et al.
Health Psychol . 2022 Dec; 42(2):103-112. PMID: 36548078
Background: We examined whether the difficulties of patients with somatoform disorders (SFDs) in integrating medical reassurance can be altered by preventing patients from devaluing reassuring information through defensive cognitive strategies....
6.
Using clinical patient characteristics to predict treatment outcome of cognitive behavior therapies for individuals with medically unexplained symptoms: A systematic review and meta-analysis
Sarter L, Heider J, Witthoft M, Rief W, Kleinstauber M
Gen Hosp Psychiatry . 2022 Apr; 77:11-20. PMID: 35390568
Objective: For individuals with medically unexplained symptoms (MUS), cognitive behavioral therapy (CBT) is the best-evaluated treatment. This systematic review and meta-analyses identify clinical patient characteristics associated with the treatment outcome...
7.
Symptom change trajectories in patients with persistent somatic symptoms and their association to long-term treatment outcome
Senger K, Rubel J, Kleinstauber M, Schroder A, Kock K, Lambert M, et al.
Psychother Res . 2021 Oct; 32(5):624-639. PMID: 34711141
Objective: This study investigated symptom change trajectory for patients with persistent somatic symptoms (PSS) during psychotherapy and the association of these patterns with pre-treatment characteristics and long-term outcome. Methods: Growth...
8.
Network Analysis of Persistent Somatic Symptoms in Two Clinical Patient Samples
Senger K, Heider J, Kleinstauber M, Sehlbrede M, Witthoft M, Schroder A
Psychosom Med . 2021 Aug; 84(1):74-85. PMID: 34428004
Objective: Previous attempts to group persistent somatic symptoms (PSSs) with factor-analytic approaches have obtained heterogeneous results. An alternative approach that seems to be more suitable is the network theory. Compared...
9.
Predicting optimal treatment outcomes using the Personalized Advantage Index for patients with persistent somatic symptoms
Senger K, Schroder A, Kleinstauber M, Rubel J, Rief W, Heider J
Psychother Res . 2021 Apr; 32(2):165-178. PMID: 33910487
Because individual patients with persistent somatic symptoms (PSS) respond differently to treatments, a better understanding of the factors that predict therapy outcomes are of high importance. Aggregating a wide selection...
10.
Cognitive and emotional variables predicting treatment outcome of cognitive behavior therapies for patients with medically unexplained symptoms: A meta-analysis
Sarter L, Heider J, Kirchner L, Schenkel S, Witthoft M, Rief W, et al.
J Psychosom Res . 2021 Apr; 146:110486. PMID: 33879330
Objective: Cognitive behavior therapy (CBT) is the best-evaluated psychological approach to treat patients with medically unexplained symptoms (MUS). We still need a better understanding of what characterizes patients with MUS...